Since June 1st 2020 EUROoCS has implemented an Industrial Advisory Board (IAB), consisting of six members from important industrial stakeholders and chaired by Thomas Singer from Roche.

The IAB advises the EUROoCS Board on translational aspects and industrial adoption of the technology. Among other tasks, the IAB will scout for new relationships for EUROoCS among companies in order to catalyse greater industry involvement and collaboration in research activities.
The IAB will support the EUROoCS community in strengthening science and technology and promoting the acceptance of Organ-on-Chip technology by the health authorities. Members are appointed for three years and are eligible for re-appointment for another three years.

During the EUROoCS 2020 conference, Christine Mummery introduced the members and mentioned that their input and advice in promoting the visibility and utility of Organ-on-Chip, in many facets of the life sciences and engineering, is highly appreciated.

The members of the IAB are:

Thomas Singer (Chair)
Global Head of Pharmaceutical Sciences/ Senior Vice President
Roche Pharmaceutical Research and Early Development
Roche Innovation Center Basel, Basel Switzerland

Lisa Benincosa
Global Head of Translational Medicine
Merck KGaA
Darmstadt, Germany

Eckhard von Keutz
Senior Vice President and Head of Translational Sciences
Bayer AG
Research & Development, Pharmaceuticals
Translational Sciences
Wuppertal, Germany

Jochen Kühnl
Lab Manager
Representative Cosmetics Europe
Beiersdorf, Hamburg, Germany

Bennard Ravenzwaay
Senior Vice President
BASF SE, Ludwigshafen am Rhein, Germany

Armin Wolf
Chief Scientific Officer InSphero AG, Schlieren, Switzerland
Technical University of Kaiserslautern, Department of
Chemistry, Kaiserslautern, Germany